Lecture 2 – Muscle Damage, Regeneration, and Protective Strategies
Overview / Scope of the Lecture
- Focus: Ageing, myogenesis, muscle injury, repair mechanisms, and protection strategies.
- Clinical relevance:
- Ageing populations live longer but often with lower tissue quality.
- PT goal = optimise FUNCTION by manipulating muscle structure & metabolism.
- Potential to coordinate myogenesis to create cultured meat without animal slaughter.
- Lecture roadmap:
- How muscles get damaged (mechanisms & models).
- Factors that enable or compromise repair.
- Functional implications for PT / strength-conditioning.
- Protective interventions (training, pharmacology, tissue engineering).
Major Modes of Muscle Damage
- Strain / sports tears (eccentric overload).
- Surgical injury (esp. ischaemia–reperfusion during orthopaedic occlusion).
- Laceration (open wounds).
- Crush (industrial accidents, impact trauma).
- Temperature extremes.
- Chemical & injectable toxins (research models):
- Local anaesthetic (bupivacaine).
- Snake venom myotoxins.
- BaCl2, glycerol.
- Contraction-mediated injury (activation + lengthening).
- Shared outcome: initial degeneration → inflammation → regeneration ± fibrosis.
Experimental Injury Models & Insights
- Forceps crush: damages fibres and extracellular matrix (ECM), blood vessels, nerves → high fibrosis.
- Laceration: similar multi-structure compromise.
- Myotoxin injection (e.g.
bupivacaine, venom): destroys fibres but spares ECM scaffold → near-perfect regeneration. - Key principle: Outcome depends on whether ECM / neurovascular supply remain intact.
Phases of Muscle Repair
- Degeneration / Necrosis
- Fibre breakdown, membrane rupture, Ca2+ influx.
- Robust inflammatory response (neutrophils → macrophage M1 → M2).
- Regeneration
- Satellite cells (muscle stem cells) exit quiescence, proliferate, migrate, fuse.
- Centrally-located nuclei = histological hallmark.
- Requires preserved ECM tubes for guidance.
- Remodelling vs Fibrosis
- Balance between myogenesis & collagen deposition.
- Excess TGF-β → fibrotic scar, ↓ specific force.
- Temporal overlap: phases are not discrete rectangles but inter-digitating diamonds.
Molecular / Cellular Players in Myogenesis
- Satellite cell niche: between basal lamina & sarcolemma.
- Key myogenic regulatory factors (MRFs):
- MyoD, MyoG, Myf5, MRF4.
- Orchestrated expression waves ("biological orchestra").
- Other signals: IGF-1, HGF, FGF, Notch/Delta, Wnt, inflammatory cytokines.
- Successful regeneration = precise temporal control; mistiming → failed repair or fibrosis.
- Types of contractions:
- Concentric (shortening), Isometric, Eccentric (lengthening under load).
- During eccentric:
- Cross-bridges forced to detach while generating force → high stress.
- Force magnitude ∝ level of activation × length change (∆L).
- Sarcomere inhomogeneity hypothesis:
- Biological variability → some sarcomeres start longer.
- On stretch they “pop” to excessively long lengths (no overlap).
- Produces uneven stress, Z-line streaming, myofibril disruption.
- Mechanical + electrical failure:
- T-tubule distortion → impaired Ca2+ release → excitation–contraction uncoupling.
- Markers of damage:
- Creatine kinase (CK) leakage: ↑ 24–48 h; highly variable.
- Delayed onset muscle soreness (DOMS).
- Maximal voluntary contraction (MVC) deficit = most valid non-invasive index.
- Light microscopy: Z-line streaming 2–3 d later; EM: disrupted myofilament lattice immediately post-stretch.
- Repeated-bout effect:
- 2nd identical bout at ≈2–4 wk → far smaller CK & strength loss.
- Hypotheses: sarcomere addition in series, strengthened ECM–costamere network, improved membrane repair.
Calcium, Membrane Resealing & Secondary Injury
- Membrane tears → Ca2+ influx.
- Low/moderate Ca2+ rise: recruits dysferlin, annexins → patch repair.
- Excess Ca2+: activates phospholipases & proteases (calpains) → further myofibrillar degradation (secondary injury).
- Adequate buffering + quick reseal prevent runaway damage.
Inflammation – Double-Edged Sword
- Essential tasks:
- Debridement of necrotic tissue.
- Paracrine activation of satellite cells.
- Over- or under-shoot → impaired regeneration.
- Pharmacologic dilemma: aggressive NSAID / corticosteroid use can blunt needed signals.
ECM, Costameres & Functional Recovery
- Costameres = integrin- & dystrophin-rich protein complexes tethering Z-lines to ECM.
- Force transmission path: sarcomere → costamere → ECM → tendon.
- Missing / malformed costameres (e.g.
dystrophin deficiency) → weak contractions despite fibre regeneration. - Full strength = biochemical maturity + re-established force-pathway.
Time-Course of Force Recovery (Animal Data)
- Fast twitch EDL (rat):
- 7d: large force deficit.
- 14d: improving.
- 21d: near baseline.
- 60d: full restoration.
- Slow twitch Soleus:
- Still ↓ force at 60d.
- Implication: muscle-specific rehab timelines needed.
Influence of Host Environment (Age, Vascular & Neural Supply)
- Classic cross-transplant / parabiosis studies (Carlson & Faulkner; Rando):
- Young host circulation rescues old muscle grafts.
- Old host impairs young graft.
- "Heterochronic parabiosis" (young+old blood mix) improves old regeneration.
- Ageing factors: ↓ IGF-1, testosterone, Notch signalling; ↓ neural re-innervation density.
- Adequate vascularisation & re-innervation are mandatory for full regeneration.
Pathological & Special Cases
- Muscular dystrophies: fragile sarcolemma → chronic cycles of damage/repair, satellite cell exhaustion, fatty-fibrotic replacement.
- Massive crush / laceration: ECM, vessels, nerves destroyed → high fibrosis, poor function.
- Species effect: small mammals (mouse) repair faster than large (human).
Protective & Therapeutic Strategies
- Training-Based
- Eccentric-biased pre-conditioning (repeated-bout effect).
- Balanced load & recovery; over-training negates protection.
- Strength & Conditioning Principles
- Sarcomere addition in series by training at longer muscle lengths.
- Hypertrophic strengthening of ECM-costamere complex.
- Acute Care
- RICE (rest-ice-compression-elevation) + judicious loading.
- Monitor MVC deficit > pain as return-to-play criterion.
- Biological / Pharmacological
- Growth factors: IGF-1, HGF, VEGF for angiogenesis.
- Anti-fibrotics: losartan, decorin, TGF-β blockers.
- Controlled pro-inflammatory stimuli or immune-modulation.
- Stem-cell therapies (satellite cells, induced pluripotent cells).
- Gene editing (e.g.
dystrophin restoration).
- Tissue Engineering
- Biomimetic scaffolds replacing lost ECM.
- Seeding with myogenic cells ± vascular endothelial cells.
- Goal: functional, force-producing grafts; not mere cosmetic fillers.
Clinical / Ethical / Future Implications
- Ageing rehab: manipulate systemic milieu (exercise, nutrition, anabolic hormones) to recreate "young" environment.
- Sports medicine: weigh pressure for fast return vs biologically required ≈6–8 wk regeneration.
- Cultured meat production: master orchestration of MRFs & scaffolds to grow animal-free muscle tissue.
- Potential pitfalls: unregulated stem-cell clinics, doping concerns, off-target effects of growth factors.
- Ongoing research aims:
- Fine-tune inflammation.
- Boost re-innervation & angiogenesis.
- Engineer ECM substitutes.
- Understand satellite-cell exhaustion in chronic disease.
Key Take-Home Points
- Damage type dictates outcome: fibre-only vs multi-structure injuries.
- Mechanical eccentric injury = sarcomere popping + E–C uncoupling.
- Inflammation is required, not evil; timing & magnitude matter.
- Successful regeneration demands intact ECM scaffold, blood & nerve.
- Ageing deficits are largely extrinsic, not intrinsic; environment can be modulated.
- Strength returns slower than histology; force testing best guides rehab.
- Protective adaptations can be trained; over-training nullifies them.
- Future therapies merging biology & engineering hold promise for full functional restoration.